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Producing antibodies usually takes more than three months. In the present study, we intro-
duce a faster way of producing polyclonal antibodies based on preparation of the recombi-
nant oligopeptide as antigen followed by immunization of rats. Using this method, we pro-
duced antisera against two mouse proteins: ERGIC-53 and c-Kit. An expression vector
ligated with a pair of complementary synthetic oligodeoxyribonucleotides encoding the pro-
tein was introduced into bacteria, and the recombinant oligopeptide fused with the carrier
protein glutathione-S-transferase was purified. Wistar rats were immunized by injecting the
emulsified antigen subcutaneously into the hind footpads, followed by a booster injection
after 2 weeks. One week after the booster, the sera were collected and examined for the
antibody titer by immunohistochemistry. Antisera with 1600-fold titer at the maximum were
obtained for both antigens and confirmed for their specificity by Western blotting. Anti-
ERGIC-53 antisera recognized acinar cells in the sublingual gland, and anti-c-Kit antisera
recognized spermatogenic and Leydig cells in the testis. These antisera were applicable to
fluorescent double immunostaining with mouse monoclonal or rabbit polyclonal antibodies.
Consequently, this method enabled us to produce specific rat polyclonal antisera available
for immunohistochemistry in less than one month at a relatively low cost.
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I. Introduction
Antibodies are indispensable tools to analyze protein
functions in the broad area of life science. They are par-
ticularly useful for immunohistochemistry, a technique that
visualizes the specific tissue- and cellular localization of
proteins and other antigens [2, 8]. In many instances, we
can purchase monoclonal and polyclonal antibodies from
commercial sources, or obtain them from other researchers.
However, in such cases where we are to study novel or rare
proteins or when commercial antibodies are of unsatisfacto-
ry quality, we need to produce the antibodies for ourselves
or order them as custom products.
In general, producing antibodies, whether they are
polyclonal or monoclonal, is costly and time-consuming [3].
When producing polyclonal antibodies in rabbits, many
researchers, unless they own the antigen proteins purified
from living sources, employ either recombinant proteins or
synthetic oligopeptides as antigens. Recombinant proteins
are usually produced in bacteria by introducing the expres-
sion vector ligated with the entire coding sequence of anti-
gen proteins. However, the full-length proteins produced by
bacteria are often difficult to isolate because of their insolu-
bility. Synthetic oligopeptides are composed of 10 to 25
amino acid residues representing portions of the antigen pro-
teins that possess high specificity and antigenicity. How-
ever, it usually requires several weeks of time and consider-
able cost to obtain oligopeptides as custom products. In both
cases, two or more rabbits are immunized by repeatedly
injecting the antigens subcutaneously at two-week intervals
over a period of a few months. Consequently, the total time
required for antigen preparation and immunization exceeds
three months. On the other hand, when producing mono-
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clonal antibodies in mice, the whole procedure consisting of
immunization of inbred (Balb/c) mice by injecting the anti-
gens intraperitoneally, fusion of splenic B lymphocytes with
myeloma cells, and cloning of the hybridoma cell strain in
culture takes at least six months.
Recently, Sado et al. introduced a novel way of produc-
ing monoclonal antibodies in rats called the “rat lymph node
method” [5, 9, 10]. This method is characterized by injection
of antigens into the skin of footpads followed by collection
of B cells from medial iliac lymph nodes in an inbred
(WKY) rat strain. This method takes a much shorter time
than the ordinary method of mouse monoclonal antibody
production, because it employs only a single injection of
antigen followed by collection of lymph nodes two weeks
later. Although the same authors suggested that the antisera
collected from the rats at the time of sacrifice would be
available as polyclonal antibodies, the antisera often have
too low antibody titers for use in immunohistochemistry,
probably because of the short immunization period. The
booster immunization was avoided in this method for the
purpose of increasing the frequency of positive hybridomas
after the fusion of B cells with myeloma cells.
These considerations led us to explore an improved
method of obtaining polyclonal antibodies in a much shorter
time. This method includes production of the recombinant
oligopeptide in bacteria and modification of the rat lymph
node method for producing polyclonal antibodies. In the
present study, we used this new method to raise antisera
against two distinct membranous proteins, ERGIC-53 and
c-Kit. ERGIC-53 is a transmembrane animal L-type lectin
known to be involved in the transport of certain glycopro-
teins from the rough endoplasmic reticulum (ER) to Golgi
apparatus in the early secretory pathway. A subcellular
membrane structure named ER-Golgi intermediate compart-
ment (ERGIC) has been postulated based on the localization
of ERGIC-53 [14]. C-Kit is a transmembrane receptor tyro-
sine kinase and postulated to play roles in the early develop-
mental phenomena including hematopoiesis, gametogenesis
and melanogenesis. In the testis, c-Kit is considered as
a marker of the differentiating spermatogonia and Leydig
cells [17]. Several new findings using these polyclonal
antisera in mouse sublingual gland and testis will be
presented.
II. Materials and Methods
Animals
Ten-week-old female Wistar rats for immunization and
ten-week-old male Slc:ddY mice for immunohistochemis-
try, both in closed colonies, were purchased from Nippon
SLC, Inc. (Hamamatsu, Japan). They were maintained under
12 hr light/12 hr dark laboratory conditions with free access
to the standard food and water. All procedures were per-
formed according to the Guidelines for the Care and Use of
Laboratory Animals in Kanazawa University.
Preparation of antigens
Pairs of complementary synthetic oligodeoxyribo-
nucleotides for ERGIC-53 (GenBank accession number,
AK011495), and c-Kit (GenBank accession number, NM_
021099 [1]) were purchased from Japan BioService (Asaka,
Japan) as custom products. The sense and antisense strands
were designed to form a double stranded DNA that contains
a cDNA portion coding 12 or 15 amino acids of ERGIC-53
or c-Kit, respectively, a stop codon, and the EcoRI and
SalI restriction enzyme sites at the 5' and 3' ends, respec-
tively (Fig. 1). They were annealed by incubating in TE
buffer with 150 mM sodium chloride for 10 min at 65C
and then allowed to cool down to room temperature (RT).
The resultant double stranded DNA was ligated with the
bacterial expression vector pGEX-6p-1 (Amersham Phar-
macia Biotech, Uppsala, Sweden) at the EcoRI/SalI restric-
tion enzyme sites within the multicloning site located
downstream of the promoter and glutathione-S-transferase
(GST)-coding regions. The constructed vector was then
introduced into the bacteria BL21 (Novagen, Madison, WI)
and a transformed colony was picked up and cultured in
ampicillin-containing LB medium up to the optical density
0.5 (600 nm) at 37C. Expression of the recombinant oligo-
peptide fused with the carrier protein GST was induced
by adding 1 mM isopropyl-1-thio--D-galactopyranoside
(IPTG) to the media and further incubating the bacteria for
2 hr at 37C. The bacteria were then homogenized in B-
PER bacterial protein extraction reagent (Pierce, Rockford,
IL). Following centrifugation of the homogenate, the
supernatant containing the soluble recombinant GST-fused
oligopeptide (subsequently called the recombinant protein)
for ERGIC-53 or c-Kit was incubated with Glutathione
Sepharose 4B (Amersham Pharmacia Biotech) overnight
at 4C. The complex of the recombinant protein and Glu-
tathione Sepharose 4B was washed once with PBS contain-
ing 0.1% Triton-X by centrifugation, 4 times with PBS
and then eluted 4 times with 20 mM glutathione in 0.1 M
Tris-HCl (pH 8.0) containing 0.1 M sodium chloride. The
concentration and molecular weight of the recombinant pro-
tein in the eluent was estimated by SDS-polyacrylamide gel
electrophoresis (PAGE). An aliquot of the eluent was elec-
trophoresed in an acrylamide gel, stained with Coomassie
brilliant blue for 1 hr, and then washed in the destaining
solution containing 5% acetic acid and 7.5% methanol over-
night.
Immunization of rats and production of polyclonal antibodies
Female Wistar rats were anesthetized with sodium
pentobarbital (75 mg/kg body weight) by intraperitoneal
injection, and a 100 l peripheral blood sample was col-
lected from the tail vein for preparation of preimmune serum.
Three rats were immunized for each antigen. Each rat was
injected subcutaneously in the hind footpads with 200 l
emulsion containing 200 g recombinant protein as antigen
in physiological saline and Freund’s complete adjuvant
(Difco, Detroit, MI) mixed at 1:1 (Fig. 2). Two weeks later,
a 100 l blood sample was collected for measurement of theRat Polyclonal Antibody Production 81
Fig. 1. Antigen preparation method. (A, B) Pairs of complementary synthetic oligodeoxyribonucleotides for ERGIC-53 (A) or c-Kit (B) were
annealed to form a double-stranded DNA that contains a cDNA portion encoding ERGIC-53 or c-Kit, a stop codon, and the EcoRI and SalI
restriction enzyme sites. (C) The double-stranded DNA was ligated with the bacterial expression vector pGEX-6p-1 (Amersham Pharmacia Bio-
tech, Uppsala, Sweden) at the EcoRI/SalI restriction enzyme sites located downstream of the promoter and Glutathione-S-transferase (GST)-
coding regions.
Fig. 2. Immunization method. (A) The antigen emulsified with the adjuvant was injected subcutaneously into the hind footpads of rats. (B) The
initial immunization was performed at 0 week followed by the booster after 2 weeks. Sera were collected at 0, 2 and 3 weeks after the initial
immunization.Wakayama et al. 82
serum antibody titers, followed by a booster injection of the
animals with the same amount of antigen emulsified with
Freund’s incomplete adjuvant. One week after the booster,
the animals were sacrificed by deep anesthesia, the whole
blood was collected through the pulmonary vein, and the
serum was separated by leaving the blood for 30 min at
37C, followed by centrifugation. After determination of the
antibody titers, aliquots of the antisera for practical use were
absorbed with GST at a concentration of 100 g/ml for 1 hr
at RT to block the antibodies reactive with GST and stored
at 4C with 0.05% sodium azide. The remaining antisera
were stored at 80C. All subsequent experiments were per-
formed with the GST-absorbed antisera.
Western blot analysis
Aliquots of cell lysates from mouse sublingual gland
and testis containing 30 g proteins were subjected to SDS-
PAGE followed by transfer to PVDF membranes (Bio-Rad
Laboratories, Hercules, CA). The blots were incubated with
rat anti-mouse ERGIC-53 antisera at 1:2000 dilution or anti-
mouse c-Kit antisera at 1:3000 dilution at 4C overnight.
After washing, the blots were further incubated with horse-
radish peroxidase-labeled anti-rat IgG antibody (DAKO,
Glostrup, Denmark) at 1:5000 dilution for 1 hr at RT. The
immunoreaction was detected with X-ray film (Kodak, New
Haven, CT, USA) after treatment of the blots with a chemi-
luminescent reagent ECL-plus (Amersham Pharmacia Bio-
tech, Uppsala, Sweden).
Tissue preparation and antibody titration with 
immunohistochemistry
Male Slc:ddY mice were anesthetized with sodium
pentobarbital, killed by bleeding from the right atrium, and
perfused transcardially with cold physiological saline fol-
lowed by 4% cold paraformaldehyde (Nacalai Tesque,
Kyoto, Japan) in 0.1 M phosphate buffer (pH 7.4) for fixa-
tion. The sublingual gland and testis were dissected out,
further immersed in the same fixative overnight at 4C and
then rinsed in PBS containing 30% sucrose overnight at 4C
for cryoprotection. They were then frozen and cut into 8-m
sections using a cryostat (Leica Microsystems, Wetzlar,
Germany).
For fluorescent immunostaining, the sections were
treated with 5% normal goat serum in PBS for 1 hr to pre-
vent non-specific antibody binding. Subsequently, the sec-
tions of sublingual gland or testis were incubated overnight
at 4C with the samples of rat anti-mouse ERGIC-53 or anti-
mouse c-Kit antisera diluted 25 to 3200 times with PBS. For
control, the preimmune serum was used with the same dilu-
tion. After washing the sections with PBS, the immunoreac-
tion was visualized by incubating the sections with either
anti-rat IgG antibodies or anti-rat IgM antibodies conjugated
with Alexa Fluor 594 (Molecular Probes, Eugene, OR) at
1:400 dilution for 1 hr at RT. After washing, the sections
were mounted in glycerol and subjected to examination with
a fluorescent microscope (Olympus BX50/BX-FLA) using
green emission. The number of the maximum dilution of
antisera to provide positive immunoreaction in the subman-
dibular gland (for ERGIC-53) or testis (for c-Kit), as com-
pared with the negative reaction with the same dilution of
preimmune serum, was defined as the antibody titer of the
antisera. Both the titers for IgG and IgM antibodies were
obtained by using Alexa Fluor 594-labeled anti-IgG and
anti-IgM secondary antibodies, respectively.
Fluorescent double-immunostaining
The sections of sublingual gland were incubated with
the mixture of rat polyclonal anti mouse ERGIC-53 antisera
(1:400 dilution) and mouse anti-BiP/GRP78 monoclonal
antibody (BD Biosciences; San Jose, CA; 2 g/ml) or mouse
anti-GM130 monoclonal antibody (BD Biosciences; San
Jose, CA; 5 g/ml) overnight at 4C. Similarly, the sections
of testis were incubated with the mixture of rat anti-mouse c-
Kit antisera (1:400 dilution) and rabbit anti-mouse SgIGSF
polyclonal antibodies ([15, 16]; 1 g/ml) overnight at 4C.
After washing with PBS, the sites of immunoreaction were
visualized by incubating the sections successively with the
mixture of Alexa Fluor 594-labelled anti-rat IgG (1:400
dilution) and Alexa Fluor 488-labelled anti-mouse IgG
(1:400 dilution) or Alexa Fluor 488-labelled anti-rabbit IgG
(1:400 dilution) antibodies for 1 hr at RT. After washing, the
sections were counterstained in the nuclei with 10 ng/ml of
Hoechst 33258 (Sigma-Aldrich, St. Louis, MO) for 5 min,
mounted in glycerol and subjected to examination with a
fluorescent microscope (Olympus BX50/BX-FLA, Tokyo,
Japan) using green emission for Alexa Fluor 594, blue
emission for Alexa Fluor 488 and UV emission for Hoechst
33258. To confirm specificity of the immunoreaction, the
primary antisera were replaced with the preimmune serum
or preabsorbed with the antigen used for the immunization
(50 g recombinant protein in 1 ml of diluted antisera) for
1 hr at RT prior to use.
III. Results
Production of recombinant oligopeptides as antigens
The recombinant oligopeptides for ERGIC-53 and c-
Kit, which were purified by absorbing the bacterial homoge-
nates with Glutathione-Sepharose 4B, were subjected to
analysis with SDS-PAGE (Fig. 3). Single protein bands
about 30 kDa in size, representing the fused proteins of GST
(25 kDa) and oligopeptides, were detected without contami-
nation with other bacterial proteins.
Production of the antisera in rats
The titers of the IgG and IgM antibodies against
ERGIC-53 and c-Kit were measured in the sera of 3 rats for
each antigen at two time points, i.e., two weeks after the
initial immunization and one week after the single booster
immunization (Fig. 4A, B). For both antigens, the titers of
the IgG antibodies were no more than 200-fold the first
time but showed remarkable rises the second time, up to as
high as 1600-fold, suggesting the effectiveness of the single
booster immunization. There was some heterogeneity in theRat Polyclonal Antibody Production 83
antibody titers among the rats immunized with c-Kit. Rats
with a lower titer the first time tended to show a compara-
tively lower titer the second time. In contrast, those with
titers of IgM antibodies that were 50–400-fold the first time
tended to remain as low as 50–100-fold the second time,
suggesting that the majority of antibodies produced after the
booster belonged to IgG.
Specificity of the antisera
On Western blot analysis, the mouse sublingual gland
showed a single immunopositive band of about 58 kDa in
size, which is consistent with known 517 amino acid resi-
dues for mouse ERGIC-53 (GenBank accession number,
NP_081676). Also, the testis showed a broad immunoposi-
tive band of about 140–160 kDa in size representing mouse
c-Kit [1] (Fig. 5). There was no extra immunopositive band
including the one for GST about 25 kDa in size. These
results indicated that the present rat antisera specifically
recognized mouse ERGIC-53 or c-Kit.
Immunohistochemical characterization of the antisera
In the mouse sublingual gland, rat anti-ERGIC-53 anti-
sera primarily immunostained acinar cells, where the immu-
noreactivity appeared to be localized to thin cytoplasmic
areas outside the secretory granules (Fig. 6A, B). Absorption
of the primary antibodies with the antigen recombinant pro-
tein eliminated the immunostaining completely, confirming
the specificity of the antisera (Fig. 6C). To further determine
the subcellular localization of ERGIC-53, double immuno-
staining was performed using rat anti-ERGIC-53 antisera
Fig. 3. SDS-PAGE analysis of the recombinant GST-fused oligo-
peptides for ERGIC-53 (lane 2) and c-Kit (lane 3). Aliquots of the
bacterial products purified with Glutathione Sepharose 4B were
electrophoresed and stained with Coomassie brilliant blue. The
standard markers were also electrophoresed (lane 1) with the
molecular weights indicated.
Fig. 4. Histograms showing antibody titers in the antisera for
ERGIC-53 and c-Kit collected at 2 and 3 weeks after the initial
immunization. The antibody titer was defined as number of the
maximum dilution of antisera that gives the positive immunostain-
ing. (A) Titers of the IgG-class antibodies. (B) Titers of the IgM-
class antibodies in the same antisera as in A.
Fig. 5. Western blot analysis showing ERGIC-53 in mouse sub-
lingual gland (A) and c-Kit in testis (B). The homogenate sample
from each organ was electrophoresed, blotted and immunostained
with anti-ERGIC-53 antisera or anti-c-Kit antisera. The positions
of the molecular weight markers are indicated.Wakayama et al. 84
combined with the mouse monoclonal antibody against BiP/
GRP78, an ER marker [6], or GM130, a cis-Golgi marker
[7]. The immunoreactivity for ERGIC-53 overlapped par-
tially, but not completely, with that for both BiP/GRP78 and
GM130 (Fig. 6D–I). In the mouse testis, rat anti-c-Kit anti-
sera immunostained the plasma membrane of Leydig cells
and a subpopulation of seminiferous epithelial cells (Fig.
7A, B). Again, absorption of the primary antibodies elimi-
nated the immunostaining completely (Fig. 7C). Double
immunostaining was performed using anti-c-Kit antisera
combined with the rabbit polyclonal antibodies against
SgIGSF, an adhesion molecule known to be expressed in
spermatogenic cells [15] (Fig. 7A–F). SgIGSF was localized
to the membrane of both elongating spermatids and the
earlier-phase spermatogenic cells located on the basement
membrane. The latter cell population overlapped with c-Kit-
positive spermatogenic cell population almost completely.
Fig. 6. Light micrographs showing the fluorescent immunohistochemical analysis of mouse sublingual gland for ERGIC-53. (A) A section was
immunostained with anti-ERGIC-53 antisera at 400-fold dilution. The immunoreactivity (red) is present in the cytoplasmic regions of acinar
cells outside the secretory granules. (B) The same section was counterstained with Hoechst 33258 (blue) in the nucleus. (C) The neighboring
section was immunostained with the antigen-absorbed anti-ERGIC-53 antisera. No immunoreaction is recognized. (D–F) Double immunostain-
ing of a section with anti-ERGIC-53 antisera and mouse monoclonal anti-BiP/GRP78 antibodies. The immunoreactivities for ERGIC-53 (red,
D) and BiP/GRP78 (green, E) in the acinar cells slightly overlap (yellow) when the picture is merged (F). (G–I) Double immunostaining of a
section with anti-ERGIC-53 antisera and mouse monoclonal anti-GM130 antibodies. The immunoreactivities for ERGIC-53 (red, G) and
GM130 (green, H) in the acinar cells moderately overlap (yellow) when the picture is merged (I). Bars100 m (A–C) and 25 m (D–I).Rat Polyclonal Antibody Production 85
IV. Discussion
The present method of producing antibodies available
for immunohistochemistry as well as Western blotting is
novel in two respects: the preparation of the recombinant
oligopeptide as antigen and the immunization of rats to raise
polyclonal antisera. To prepare the antigen, we used syn-
thetic complementary oligodeoxyribonucleotides designed
to produce a double-stranded DNA flanked by the restric-
tion enzyme sites, which was then ligated with the bacterial
expression vector to produce recombinant oligopeptides.
Similar use of oligodeoxyribonucleotides was introduced by
Sasaki et al. [12] to produce labeled ribonucleotide probes
for  in situ hybridization. The recombinant oligopeptide
adopted in the present method possesses advantages of both
the recombinant full-length protein and the synthetic oligo-
peptide. The recombinant oligopeptide, like the recombi-
nant full-length protein, can yield a large amount of antigen
fused with the carrier protein GST as bacterial product.
Furthermore, the former is more easily solubilized than the
latter due to its lower molecular weight. On the other hand,
the recombinant oligopeptide, like the synthetic oligopep-
tide, can be designed according to the selective sequence
with high specificity and antigenecity. Although the former
cannot be obtained as a custom product like the latter, it is
less expensive and requires a shorter time to produce.
We employed the rat as an immune animal, which is
much less expensive and requires much smaller amount of
antigens (less than 1 mg per animal) than the rabbit. To
obtain polyclonal rat antibodies, we employed the “rat
lymph node method”, which was originally developed for
monoclonal antibody production [9], with several modifica-
tions. Firstly, we used Slc:Wistar, a rat strain in a closed-
colony, instead of WKY, an inbred rat strain used in the
original method. The former is less expensive than the lat-
ter, whereas we confirmed in a preliminary experiment
that there is no difference in serum antibody titers between
the two strains. Secondly, we administered emulsified anti-
gens into the hind footpad through the subcutaneous route,
instead of the intracutaneous route adopted in the original
method. This is because the original method was intended to
restrict the immune reaction to medial iliac lymph nodes to
obtain monoclonal antibody-producing lymphocytes in high
frequencies [9], whereas the present method was intended
simply to raise polyclonal antisera. Finally, we performed
a booster immunization that was avoided in the original
Fig. 7. Light micrographs showing the fluorescent immunohistochemical analysis of mouse testis for c-Kit. (A) A section was immunostained
with anti-c-Kit antisera at 400-fold dilution. The immunoreactivity (red) is present in the basal regions of seminiferous tubules and in Leydig
cells. (B) The same section was counterstained with Hoechst 33258 (blue) in the nucleus. (C) The neighboring section was immunostained with
the antigen-absorbed anti-c-Kit antisera. No immunoreaction is recognized. (D–F) Double immunostaining of a section with anti-c-Kit antisera
and rabbit polyclonal anti-SgIGSF antibodies. The immunoreactivities for c-Kit (red, D) and SgIGSF (green, E) in the early spermatogenic cells
located at the basal regions of seminiferous epithelium mostly overlap (yellow) when the picture is merged (F). The SgIGSF-positive elongating
spermatids located at the apical regions of seminiferous epithelium are negative for c-Kit. Bars100 m (A–C) and 25 m (D–F).Wakayama et al. 86
method. A single booster proved to be sufficient to produce
more than 1000-fold titers. Repeating the booster twice or
more did not necessarily yield higher antibody titers (data
not shown). Titration of the antisera in the present method
is based on immunohistochemical staining and thus reli-
able when diluting the antisera for practical use. The total
period of 3 weeks required for immunization is much shorter
than that in rabbits, which is usually 3 months or more.
Despite the general concept that the class of immunoglobu-
lins appearing earlier is IgM, we demonstrated that most of
the rat antibodies raised after the booster is IgG. The total
volume of antisera obtained from a rat is about 5 ml, which
is much smaller than that from a rabbit but is sufficient for
use in immunohistochemical studies conducted in a single
laboratory. Also, although it is difficult to purify rat anti-
bodies into the IgG fraction because of the lower binding
affinity of rat IgG to protein A or G, they are sufficient for
the use as antisera for immunohistochemical purposes, as
long as the antibody titers are high enough.
By use of the present new method, we produced rat
antisera against ERGIC-53 and c-Kit and successfully
applied them to double-immunostaining with mouse mono-
clonal and rabbit polyclonal antibodies, respectively. Since
the majority of antibodies used for immunohistochemistry
are mouse monoclonal and rabbit polyclonal antibodies, it is
a great advantage of rat polyclonal antisera to be able to
be combined with both types of antibodies for double-
immunostaining. The present anti-ERGIC-53 antisera immu-
nostained the sublingual acinar cell, a mucus glycoprotein-
producing cell population. ERGIC-53 is a type I membrane
protein belonging to a family of animal L-type lectins [13].
ERGIC-53 with its luminal domain binds glycoprotein
products in the ER and with its cytosolic domain binds
COPII and COPI, the vesicle-coating proteins involved in
ER-Golgi antero- and retrograde transports, respectively
[4]. Based on functional and molecular biological studies
conducted in cultured cells, ERGIC-53 is believed to be
responsible for vesicular transport of certain glycoproteins
from the ER to Golgi apparatus. Although the portion of
internal membrane harboring ERGIC-53 was defined as
the ERGIC, the ultrastructural basis for ERGIC is not clear.
The present study demonstrated partial overlapping of
ERGIC-53 with both ER and cis-Golgi markers, confirm-
ing that ERGIC represents the membranous compartment
intermediate of ER and cis-Golgi. We recently discovered
SLAMP, a new member of the animal L-type lectin family,
in rat and mouse sublingual glands [11]. The intracellular
localization and function of SLAMP by comparison with
those of ERGIC-53 is under investigation using the present
anti-ERGIC-53 antisera.
On the other hand, the present anti-c-Kit antisera
immunostained the spermatogenic cells located adjacent to
the basement membrane of seminiferous tubules, as well as
Leydig cells. C-Kit is a transmembrane receptor of the
cytokine Stem Cell Factor and is responsible for the survival
and/or proliferation of the differentiating type A spermato-
gonia [17]. It is generally accepted that c-Kit is a marker
of the spermatogonia populations other than the undiffer-
entiated type A spermatogonia, the spermatogenic stem cell
population. In the present study, double-immunostaining
demonstrated that most of the c-Kit-immunopositive sper-
matogenic cells are simultaneously positive for SgIGSF.
In our previous paper, we reported, based on the enzyme-
labeled antibody method, that the spermatogenic cells in
the step of intermediate (type B) spermatogonia or later
are immunopositive for SgIGSF [15]. However, the present
study, using the more sensitive fluorescent antibody method
and double-immunostaining with c-Kit, suggested that the
expression of SgIGSF begins as early as in the step of differ-
entiating type A spermatogonia. This is also consistent with
our previous finding that the seminiferous epithelium from
WWv mutant mice, which are lacking in the c-Kit gene and
hence occur in the spermatogenic cell lineage later than
the undifferentiated spermatogonia, are devoid of SgIGSF
immunoreactivity [15].
In conclusion, the present method will enable us to
produce antibodies available for immunohistochemistry in
shorter time and at lower cost.
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